Telomir Pharmaceuticals, Inc. Common Stock
Price Action
Technical Summary
CONSOLIDATINGTelomir Pharmaceuticals, Inc. Common Stock is in a consolidation phase, trading with mixed signals as moving averages converge. Relative strength is weak (RS Rating: 35), showing significant lag compared to the market leaders. Earnings growth of 59% provides fundamental context to the price action. Investors should exercise caution due to high volatility (116% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $1.26 | +2.85% | ABOVE |
| 50 SMA | $1.30 | +0.28% | ABOVE |
| 100 SMA | $1.28 | +1.40% | ABOVE |
| 150 SMA | $1.30 | -0.26% | BELOW |
| 200 SMA | $1.35 | -3.40% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is TELO in an uptrend right now?
TELO has a trend score of 2/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 2 of 4 trend criteria are met.
Is TELO overbought or oversold?
TELO's RSI (14) is 51. The stock is in neutral territory, neither overbought nor oversold.
Is TELO outperforming the market?
TELO has a Relative Strength (RS) Rating of 35 out of 99. TELO is currently lagging the broader market.
Where is TELO in its 52-week range?
TELO is trading at $1.30, which is 42% of its 52-week high ($3.10) and 12% above its 52-week low ($1.05).
How volatile is TELO?
TELO has a Beta of 1.92 and 52-week volatility of 116%. It's more volatile than the S&P 500 - expect bigger swings.